News and Updates

Discover how AI is revolutionizing clinical trials by slashing costs, optimizing patient recruitment, and accelerating the drug development pipeline.

Discover how the FDA’s new regulatory guidelines are shaping the future of psychedelic drug development and clinical research standards.

Financial burdens and clinician gatekeeping are limiting clinical trial access for Black and Hispanic children. Discover how to improve research equity.

The WHO is advancing plans for new Ebola vaccine trials in the DRC. Discover how this move aims to improve outbreak response and global health security.

Longeveron reports a widened Q2 net loss driven by rising clinical trial and legal costs. Discover how these investments impact the firm's biotech pipeline.

Ochsner Health is scaling clinical trial recruitment using AI to match patients with research faster, enhancing diversity and medical innovation.

New data from the ACC reveals a persistent leadership gap in structural heart trials, threatening research inclusivity and future clinical outcomes.

New reports indicate AI clinical monitoring in oncology can deliver 82x ROI by streamlining trial data and reducing costly operational inefficiencies.

The clinical trial supply market is set to reach $8.18B by 2030, driven by decentralized trials, cold chain demands, and growth in biologic drug development.

A first patient has completed a breakthrough cancer clinical trial, marking a major milestone in the development of life-saving, targeted therapies.